1h Free Analyst Time
The gallbladder cancer therapeutics market is forecasted to grow by USD 141.47 mn during 2023-2028, accelerating at a CAGR of 6.63% during the forecast period. The report on the gallbladder cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the strong incidence of gallbladder cancer in developing countries, risk factors of gallbladder cancer, and the advent of immunotherapy for the treatment of gallbladder cancer.
The gallbladder cancer therapeutics market is segmented as below:
By Type
- Combination therapy
- Monotherapy
By Application
- Hospitals
- Academic and medical centers
- Others
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the gallbladder cancer therapeutics market covers the following areas:
- Gallbladder cancer therapeutics market sizing
- Gallbladder cancer therapeutics market forecast
- Gallbladder cancer therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global gallbladder cancer therapeutics market: AbbVie Inc., AstraZeneca Plc, B.Braun SE, Boston Scientific Corp., Bristol Myers Squibb Co., Conmed Corp., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Medtronic Plc, Merck KGaA, Novartis AG, Olympus Corp., Pfizer Inc., Sanofi SA, Smith and Nephew plc, and Sun Pharmaceutical Industries Ltd.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is a strong pipeline for gallbladder cancer.'
According to the report, one of the major drivers for this market is the strong incidence of gallbladder cancer in developing countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- AstraZeneca Plc
- B.Braun SE
- Boston Scientific Corp.
- Bristol Myers Squibb Co.
- Conmed Corp.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- Medtronic Plc
- Merck KGaA
- Novartis AG
- Olympus Corp.
- Pfizer Inc.
- Sanofi SA
- Smith and Nephew plc
- Sun Pharmaceutical Industries Ltd.
